DOXY

This brand name is authorized in United States. It is also authorized in France, Hong Kong SAR China, Israel, New Zealand, Nigeria.

Active ingredients

The drug DOXY contains one active pharmaceutical ingredient (API):

1	Doxycycline UNII 19XTS3T51U - DOXYCYCLINE HYCLATE
	Doxycycline is primarily bacteriostatic and is believed to exert its antimicrobial effect by the inhibition of protein synthesis.
	Read more about Doxycycline

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DOXY Powder for solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01AA02	Doxycycline	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01A Tetracyclines → J01AA Tetracyclines
Discover more medicines within J01AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	61722191, 67061569
HK	Department of Health Drug Office	38107, 42036
IL	מִשְׂרַד הַבְּרִיאוּת	3532
NG	Registered Drug Product Database	B4-7010
Switch country to Nigeria in order to find specific presentations of DOXY
NZ	Medicines and Medical Devices Safety Authority	2731, 2733
US	FDA, National Drug Code	51662-1402, 52584-028, 63323-130